Immunochemical FOBTs, such as OC-Micro, OC-Sensor, or OC-Light, are moderately sensitive (73% to 89%) and highly specific (92% to 95%) for identifying colorectal cancer. In comparison, Hemoccult Sensa ...

Uncover the latest and most impactful research in Fecal Immunochemical Testing in Colorectal Cancer Screening. Explore pioneering discoveries, insightful ideas and new methods from leading researchers ...

Screening for bowel cancer using at-home fecal immunochemical tests could help to reduce the frequency of colonoscopies for some at above-average risk individuals, with a new study finding there is a ...

The number of colonoscopies needed to detect one person with advanced neoplasia was 5.1 for guaiac-positive patients but only 2.7 for immunochemical-test–positive patients. Colonoscopy revealed ...

Fecal immunochemical tests offer an effective, noninvasive approach to detect later-stage colorectal cancer (CRC); however, they lack the sensitivity to consistently detect early-stage cancers, ...

Background: Previous studies have suggested that the immunochemical fecal occult blood test has superior specificity for detecting bleeding in the lower gastrointestinal tract even if bleeding occurs ...

The accuracy of fecal immunochemical tests (FITs), which are widely used for bowel cancer screening, have been examined following exposure to different temperatures using laboratory and field ...

Annual screening by fecal immunochemical testing -- a test that detects blood in the stool, has high sensitivity and specificity, and might improve participation rates through increased patient ...

Fecal immunochemical testing should be performed every 1–2 years, ideally as part of a colorectal cancer screening program1, 2 Fecal immunochemical testing, a stool immunochemical test for occult ...

Please provide your email address to receive an email when new articles are posted on . Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage ...

COLONPREV, a trial conducted in Spain, is the first among the large colonoscopy vs FIT studies, and its results raise as many questions as it answers. At a population level and with the study's ...